INTRODUCTION
Little is known of the mechanisms regulating human fetal hemoglobin (Hb F) synthesis during fetal and adult life. In patients with hereditary persistence of fetal hemoglobin (HPFH),1 Hb F production persists in adult life. Homozygotes for HPFH have no anemia indicating that the Hb F completely compensates for the complete lack of Hbs A or A2 (1) . Unlike HPFH, in the homozygous form of P-thalassemia, where Hb A synthesis may be markedly reduced or absent, Hb F svnthesis may increase but not to a level adequate to compensate for the reduced synthesis of Hb A. In so-called Dr. Bank is a Faculty Research Scholar of the American Cancer Society.
Received for publication 2 November 1973 and in revised form 14 January 1974. 'Abbreviations used in this paper: HPFH, hereditary persistence of fetal hemoglobin; KRB, Krebs-Ringer bicarbonate; MCV, mean corpuscular volume; S-thal, sickle-, 8-thalassemia. 89-thalassemia (2) , in which Hb F is the only Hb component synthesized, the level of total hemoglobin production is also low. The molecular basis for the normal levels of hemoglobin in patients with HPFH is obscure, and studies of globin chain synthesis in these patients have been lacking.
We have studied two families with the HPFH gene.
In four generations of the first family, individuals heterozygous for HPFH and for 9-thalassemia and individuals doubly heterozygous for sickle-,B-thalassemia (S-thal) and S-F were examined. In the second family, four HPFH heterozygotes were studied. The (4) . Starch gel electrophoresis was used to measure Hb A2 (5). Agar gel electrophoresis was performed when Hb S was present and to confirm the presence and amount of Hb F.
The two families are black. The pedigree of the first family is shown in Fig. 1 . Hematological data are in Table I .
Family I. III-3 (the proband), a 24-yr-old student nurse was studied because of hyperbilirubinemia found on a routine examination. She has had no hospital admissions in New York or in Haiti, where she was born and resided until age 19. Her physical examination reveals hepatomegaly, 3 The MgSO4, 160 mM NaHCOs, 360 mM FeCi2 4H20, 100 mM inosine, 340 mM glucose, 30 mM NaCl, and amino acids (520 mM) minus leucine. In the study of certain family members, bone marrow aspirated from the posterior iliac crest was similarly studied. After incubation, the KRB was removed, and the cells lysed with four vol of water. From the lysate, globin was precipitated by extraction with acid acetone and further purified by carboxymethyl cellulose chromatography using a modification of the method originally described by Clegg, Naughton, and Weatherall (7) and detailed elsewhere (8) (Packard Instrument Co., Inc., Downers Grove, Ill.). The efficiency of counting with double label settings was 10% for 'H and 30% for "C.
RESULTS
Family I. Reticulocytes from peripheral blood of the proband (III-3) produce 2.2-fold as many a as ay chains (a/y ratio: 2.2), her a/PA being 7.7 (Table III) . As shown in Fig. 3 , the reticulocytes show an excess of a chains (a/P + y:1.73) of a moderate degree. This a/ non-a ratio is in the range of P-thalassemia heterozygotes (6); the major non-a globin contribution is by y chains (Table III) . II-3 and II-4, both S-F, show an a/P5 in peripheral blood of 1.0 and 1.4, respectively, and relatively balanced a to non-a chain synthesis (0.9 and 1.2, respectively).
These data indicate less asymmetry in a and non-a synthesis than that reported for patients with sickle-13-thalassemia (6, 9) . In addition, II-4 has balanced a/PS synthesis in bone marrow. In contrast, III-2 with S-thal shows a greater excess of a over P' globin synthesis with an a/#' of 2.0 and an a/P of 4.6. However, he com- [3H] leucine radioactivity from blood of patient II-1 of
an a/PA of 1.2 and a/P + My of 0.9. II-5 with P-thalassemia trait has an a/,8A of 1.4 and achieves balanced total globin synthesis with an a/P + -y of 1.1. Similar results have been reported in some black P-thalassemia heterozygotes. III-4, another A-F heterozygote, has an a/PA of 1.4 and completely compensates with a/P, + y of 0.9.
Family II. Three members of this family studied, II-1, II-2, and II-3, show balanced globin chain synthesis (Table IV) . The a/P3+ y ratios are 1.2, 1.1, and 1.1, respectively. I-2 has an a/,8 + y ratio of 0.7 which is lower than normal and may represent the additional presence in this patient of an a-thalassemia gene.
DISCUSSION
The HPFH gene like the 59-thalassemia gene is associated with complete suppression of the synthesis of Hb A in most cases. This is the first study of globin chain synthesis in HPFH patients to date. The results show that there is balanced globin chain synthesis in peripheral blood of heterozygotes in the two families studied here. In addition, globin synthesis is close to balanced in the two patients with S-F in family I, who are also asymptomatic clinically and have close to normal Hb levels. In these patients, balanced globin synthesis is achieved by increased activity of the y genes and the remaining P allele. The a/P ratios of 1.3-1.5 indicate compensation by the remaining p allele as well as by increased y production.
The clinical and hematological data are most consistent with the interpretation that the high F values in these two families are due to the presence of the HPFH gene. The homogenous staining for Hb F using acid elution makes it unlikely that this high F gene is due to 8,-thalassemia. HPFH is a benign state in which Hb F persists into adult life. Heterozygotes have been described from Uganda (10), Ghana (11) , Jamaica (12), Puerto Rico (13) , and the U. S. A. (14, 1), but not previously from Haiti. Homozygotes are rare and are usually asymptomatic (15) . As can be seen from these family studies, individuals with HPFH trait or doubly heterozygous for Hb S and HPFH are asymptomatic. In the doubly heterozygous S-F patients studied, the percent of Hb F is higher than in most patients with The S-F patients are also less symptomatic clinically than patients with S-thal who have no Hb A production. Globin chain synthesis in one black S-thal patient with no Hb A and in two patients of Italian origin with S-thal and no Hb A is unbalanced with relative a chain excess in peripheral blood (9, 16) . This is in contrast to the balanced a and non-a synthesis in S-F patients described here. The high A2-p8-thalassemia gene in certain black patients produces a milder clinical disorder than in patients with 9-thalassemia in other racial groups (17) . As seen in the case of II-5 of the first family with the diagnosis of mild 9-thalassemia trait, the a/P of 1.4 is well in agreement with such patients described by Braverman, McCurdy, Manos, and Sherman (18) and Schwartz (19) . Balanced globin chain synthesis in some black #-thalassemic heterozygotes is described by Friedman, Hamilton, and Schwartz (16) . The 0-thalassemic gene in family I is a P'-producing gene. In the S-thal patient, III-2, the mild clinical state is correlated with relatively balanced globin chain synthesis (a/P + y: 1.2). The mechanism for compensation in this S-thal patient differs from that of the S-F patients. In the S-F patients compensation is due to increased activity of both the pS and y genes, while in the S-thal patient pA chain synthesis contributes significantly and y synthesis is not as significant.
It is possible that the increased activity of the Y chain genes in every cell in HPFH is primarily responsible for balanced globin synthesis in patients with this disorder. If this is the only mechanism involved, why is the Y chain compensation so incomplete in 9-thalassemia, especially 5p-thalassemia? In the first family, the levels of Hb F vary from 9 to 23%, similar to that described by Schneider, Levin, and Everett (20) . In the second family, the Hb F values are higher (20-30%) as described by Conley, Weatherall, Richardson, Shepard, and Charache (1). The two types of Hb F in black patients have been shown by Sukumaran et al. (21) to contain different ratios of glycine and alanine at position 136 of the y chain. The presence of four y-producing genes, two synthesizing 136 alanine-containing ay chains (TA) and two 136 glycine-containing Y chains (-yG) has been postulated (22) . There is evidence that each of these genes leads to a unique relative amount of y chain synthesis; in addition, deletion of different of these y chain genes may account for variations in the total amount of Hb F produced in different HPFH patients.
A recent report indicates that Hemoglobin Kenya, a y-,8 fusion product is associated with a HPFH-like syndome with elevation of yG-chains primarily (23) . These findings suggest that the absence of normal S and P cis genes may permit the increased or continued expression of -Y genes. In 0-thalassemia, the persistence of actiity of either structural or regulatory a and 8 cis loci may prevent this continued or compensatory activity of a genes.
In assessing the mild clinical state in these two families, one must also consider the possibility of the presence of an a-thalassemia gene that might account for balanced globin synthesis and the mild clinical state. There is no evidence for this in either family except for patient I-1 of family II. It is clear, however, that the mild clinical syndromes in the two families are associated with a lack of excess a chains. Excess a chains have been shown to contribute to the anemia in 9-thalassemia by precipitating in erythrocytes as inclusion bodies, and decreasing the life span (24, 25) . As a consequence of the increased y globin synthesis and increased activity of the remaining Ps globin allele in the HPFH heterozvgotes described in this report, no excess a chains are produced. This may explain, in part, the absence of anemia in these patients. In addition, in a series of patients with S-thalassemia, there is a correlation between the absence of anemia and relatively balanced globin synthesis in reticulocytes (9) .
Alternatively, it is possible that the HPFH gene involves interaction of nonglobin genes with the globinproducing genes that affect the intracellular production of Hb in as yet unknown ways.
